Tristel PLC
LSE:TSTL

Watchlist Manager
Tristel PLC Logo
Tristel PLC
LSE:TSTL
Watchlist
Price: 429 GBX 0.94% Market Closed
Market Cap: 204.6m GBX
Have any thoughts about
Tristel PLC?
Write Note

Tristel PLC
Total Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Tristel PLC
Total Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Tristel PLC
LSE:TSTL
Total Current Assets
ÂŁ22.1m
CAGR 3-Years
9%
CAGR 5-Years
13%
CAGR 10-Years
14%
Abingdon Health PLC
LSE:ABDX
Total Current Assets
ÂŁ4.8m
CAGR 3-Years
-13%
CAGR 5-Years
23%
CAGR 10-Years
N/A
ConvaTec Group PLC
LSE:CTEC
Total Current Assets
$870m
CAGR 3-Years
-10%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Inspecs Group PLC
LSE:SPEC
Total Current Assets
ÂŁ98m
CAGR 3-Years
-8%
CAGR 5-Years
29%
CAGR 10-Years
N/A
Advanced Medical Solutions Group PLC
LSE:AMS
Total Current Assets
ÂŁ203m
CAGR 3-Years
25%
CAGR 5-Years
14%
CAGR 10-Years
21%
Rua Life Sciences PLC
LSE:RUA
Total Current Assets
ÂŁ5m
CAGR 3-Years
-12%
CAGR 5-Years
14%
CAGR 10-Years
N/A
No Stocks Found

Tristel PLC
Glance View

Market Cap
203.3m GBX
Industry
Health Care

Tristel Plc engages in the design, development, manufacture, and sale of infection control, contamination control and hygiene products. The company is headquartered in Snailwell, Cambridgeshire and currently employs 189 full-time employees. The company went IPO on 2005-06-01. The Company’s technology is a chlorine dioxide formulation used by hospitals for the high-level disinfection of medical devices and the sporicidal disinfection of environmental surfaces. The Company’s segments include Hospital medical device decontamination and Hospital environmental surface disinfection. The firm manufactures and sells medical device decontamination products that are used primarily for infection control in hospitals. The firm also manufactures and sells hospital environmental surface disinfection products. The Tristel brand offers airway management, cardiology, ear, nose and throat, ophthalmology, endoscopy, phlebotomy, surfaces, ultrasound, urology, and women's health. The Crystel brand offers pharmaceutical, cosmetic and toiletry (PCT), cleanroom disinfectants and laboratory disinfectants. The company markets its products under the Tristel, Anistel, and Crystel brands.

TSTL Intrinsic Value
422.12 GBX
Overvaluation 2%
Intrinsic Value
Price

See Also

What is Tristel PLC's Total Current Assets?
Total Current Assets
22.1m GBP

Based on the financial report for Dec 31, 2023, Tristel PLC's Total Current Assets amounts to 22.1m GBP.

What is Tristel PLC's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
14%

Over the last year, the Total Current Assets growth was 7%. The average annual Total Current Assets growth rates for Tristel PLC have been 9% over the past three years , 13% over the past five years , and 14% over the past ten years .

Back to Top